131 related articles for article (PubMed ID: 21457513)
1. Sepsis and the broken endothelium.
Shapiro NI; Aird WC
Crit Care; 2011 Mar; 15(2):135. PubMed ID: 21457513
[TBL] [Abstract][Full Text] [Related]
2. Plasma soluble vascular endothelial growth factor receptor-1 levels predict outcomes of pneumonia-related septic shock patients: a prospective observational study.
Yang KY; Liu KT; Chen YC; Chen CS; Lee YC; Perng RP; Feng JY
Crit Care; 2011; 15(1):R11. PubMed ID: 21219633
[TBL] [Abstract][Full Text] [Related]
3. Endothelial Permeability and Hemostasis in Septic Shock: Results From the ProCESS Trial.
Hou PC; Filbin MR; Wang H; Ngo L; Huang DT; Aird WC; Yealy DM; Angus DC; Kellum JA; Shapiro NI;
Chest; 2017 Jul; 152(1):22-31. PubMed ID: 28109962
[TBL] [Abstract][Full Text] [Related]
4. Time-course of sFlt-1 and VEGF-A release in neutropenic patients with sepsis and septic shock: a prospective study.
Alves BE; Montalvao SA; Aranha FJ; Lorand-Metze I; De Souza CA; Annichino-Bizzacchi JM; De Paula EV
J Transl Med; 2011 Mar; 9():23. PubMed ID: 21371321
[TBL] [Abstract][Full Text] [Related]
5. Vascular Endothelial Growth Factor and Soluble Vascular Endothelial Growth Factor Receptor as Novel Biomarkers for Poor Outcomes in Children With Severe Sepsis and Septic Shock.
Whitney JE; Silverman M; Norton JS; Bachur RG; Melendez E
Pediatr Emerg Care; 2020 Dec; 36(12):e715-e719. PubMed ID: 30335688
[TBL] [Abstract][Full Text] [Related]
6. A prospective, observational study of soluble FLT-1 and vascular endothelial growth factor in sepsis.
Shapiro NI; Yano K; Okada H; Fischer C; Howell M; Spokes KC; Ngo L; Angus DC; Aird WC
Shock; 2008 Apr; 29(4):452-7. PubMed ID: 18598002
[TBL] [Abstract][Full Text] [Related]
7. Association between sympathoadrenal activation, fibrinolysis, and endothelial damage in septic patients: a prospective study.
Johansson PI; Haase N; Perner A; Ostrowski SR
J Crit Care; 2014 Jun; 29(3):327-33. PubMed ID: 24581948
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor in severe sepsis and septic shock.
Karlsson S; Pettilä V; Tenhunen J; Lund V; Hovilehto S; Ruokonen E;
Anesth Analg; 2008 Jun; 106(6):1820-6. PubMed ID: 18499616
[TBL] [Abstract][Full Text] [Related]
9. The role of biomarkers of endothelial activation in predicting morbidity and mortality in patients with severe sepsis and septic shock in intensive care: A prospective observational study.
Fang Y; Li C; Shao R; Yu H; Zhang Q
Thromb Res; 2018 Nov; 171():149-154. PubMed ID: 30312800
[TBL] [Abstract][Full Text] [Related]
10. Circulating vascular endothelial growth factor (VEGF) and its soluble receptor 1 (sVEGFR-1) are associated with inflammation and mortality in incident dialysis patients.
Yuan J; Guo Q; Qureshi AR; Anderstam B; Eriksson M; Heimbürger O; Bárány P; Stenvinkel P; Lindholm B
Nephrol Dial Transplant; 2013 Sep; 28(9):2356-63. PubMed ID: 23828162
[TBL] [Abstract][Full Text] [Related]
11. Urokinase-type Plasminogen Activator (uPA) Promotes Angiogenesis by Attenuating Proline-rich Homeodomain Protein (PRH) Transcription Factor Activity and De-repressing Vascular Endothelial Growth Factor (VEGF) Receptor Expression.
Stepanova V; Jayaraman PS; Zaitsev SV; Lebedeva T; Bdeir K; Kershaw R; Holman KR; Parfyonova YV; Semina EV; Beloglazova IB; Tkachuk VA; Cines DB
J Biol Chem; 2016 Jul; 291(29):15029-45. PubMed ID: 27151212
[TBL] [Abstract][Full Text] [Related]
12. Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: relation to disease severity, multiple organ dysfunction, and mortality.
Presneill JJ; Waring PM; Layton JE; Maher DW; Cebon J; Harley NS; Wilson JW; Cade JF
Crit Care Med; 2000 Jul; 28(7):2344-54. PubMed ID: 10921563
[TBL] [Abstract][Full Text] [Related]
13. Urokinase receptor expression on human microvascular endothelial cells is increased by hypoxia: implications for capillary-like tube formation in a fibrin matrix.
Kroon ME; Koolwijk P; van der Vecht B; van Hinsbergh VW
Blood; 2000 Oct; 96(8):2775-83. PubMed ID: 11023511
[TBL] [Abstract][Full Text] [Related]
14. An early increase in endothelial protein C receptor is associated with excess mortality in pneumococcal pneumonia with septic shock in the ICU.
Chapelet A; Foucher Y; Gérard N; Rousseau C; Zambon O; Bretonnière C; Mira JP; Charreau B; Guitton C
Crit Care; 2018 Oct; 22(1):251. PubMed ID: 30290852
[TBL] [Abstract][Full Text] [Related]
15. The effects of neoadjuvant anastrozole and tamoxifen on circulating vascular endothelial growth factor and soluble vascular endothelial growth factor receptor 1 in breast cancer.
Banerjee S; Pancholi S; A'hern R; Ghazoui Z; Smith IE; Dowsett M; Martin LA
Clin Cancer Res; 2008 May; 14(9):2656-63. PubMed ID: 18451229
[TBL] [Abstract][Full Text] [Related]
16. 4G/5G polymorphism of PAI-1 gene is associated with multiple organ dysfunction and septic shock in pneumonia induced severe sepsis: prospective, observational, genetic study.
Madách K; Aladzsity I; Szilágyi A; Fust G; Gál J; Pénzes I; Prohászka Z
Crit Care; 2010; 14(2):R79. PubMed ID: 20429897
[TBL] [Abstract][Full Text] [Related]
17. Impact of type 2 diabetes on the plasma levels of vascular endothelial growth factor and its soluble receptors type 1 and type 2 in patients with peripheral arterial disease.
Wieczór R; Gadomska G; Ruszkowska-Ciastek B; Stankowska K; Budzyński J; Fabisiak J; Suppan K; Pulkowski G; Rość D
J Zhejiang Univ Sci B; 2015 Nov; 16(11):948-56. PubMed ID: 26537213
[TBL] [Abstract][Full Text] [Related]
18. The relationship of serum VEGF and sVEGFR-1 levels with vascular involvement in patients with Behçet's disease.
Sertoglu E; Omma A; Yucel C; Colak S; Sandıkcı SC; Ozgurtas T
Scand J Clin Lab Invest; 2018 Oct; 78(6):443-449. PubMed ID: 30015524
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of circulating endothelial cells in patients with severe sepsis or septic shock.
Yoo JW; Moon JY; Hong SB; Lim CM; Koh Y; Huh JW
Infect Dis (Lond); 2015 Jun; 47(6):393-8. PubMed ID: 25746599
[TBL] [Abstract][Full Text] [Related]
20. Reduced serum vascular endothelial growth factor receptor-2 (sVEGFR-2) and sVEGFR-1 levels in gastric cancer patients.
Kikuchi S; Obata Y; Yagyu K; Lin Y; Nakajima T; Kobayashi O; Kikuichi M; Ushijima R; Kurosawa M; Ueda J
Cancer Sci; 2011 Apr; 102(4):866-9. PubMed ID: 21219538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
